ENDRA Life Sciences (NDRA) Non-Current Assets (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Non-Current Assets for 11 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 146.67% year-over-year to $2.4 million in Q2 2026; TTM through Jun 2026 was $9.1 million, a 260.52% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 201.06% from the prior year.
• Non-Current Assets was $2.4 million for Q2 2026 at ENDRA Life Sciences, down from $2.9 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $3.9 million in Q4 2022 and troughed at -$4.7 million in Q3 2024.
• A 5-year average of $1.4 million and a median of $1.1 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 398.99% in 2022 and tumbled 492.79% in 2024, its largest moves.
• Over 5 years, Non-Current Assets stood at $3.9 million in 2022, then retreated by 4.45% to $3.7 million in 2023, then plunged by 176.74% to -$2.9 million in 2024, then soared by 201.06% to $2.9 million in 2025, then slipped by 18.39% to $2.4 million in 2026.
• The last three Non-Current Assets figures came in at $2.4 million (Q2 2026), $2.9 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.